Guj. Inject (Kerala)
Ticker > Company >

Guj. Inject (Kerala) share price

Gujarat Inject (Kerala) Ltd.

BSE: 524238 SECTOR: Pharmaceuticals & Drugs  6.6 K   5   0

20.46
+0.50 (2.51%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 20.48

Today's Low

₹ 19.1

52 Week High

₹ 29.12

52 Week Low

₹ 17.02

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 29.97 Cr.

Enterprise Value

₹ 27.05 Cr.

No. of Shares

1.46 Cr.

P/E

31

P/B

2.97

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  6.89

CASH

₹ 2.92 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  0.66

Sales Growth

3231.11%

ROE

3.44 %

ROCE

2.54%

Profit Growth

101.63 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3231.11%
3 Year694.3%
5 Year∞%

Profit Growth

1 Year101.63%
3 Year40.72%
5 Year78.41%

ROE%

1 Year3.44%
3 Year1.15%
5 Year0.69%

ROCE %

1 Year2.54%
3 Year0.85%
5 Year0.51%

Debt/Equity

0

Price to Cash Flow

-4.97

Interest Cover Ratio

237.7054

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 0.00 0.00
Mar 2025 0.00 0.00
Dec 2024 0.00 0.00
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 694.295085793102% for the Past 3 years.
  • The company has significantly decreased its debt by 0.6076555 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -14.6229 days.
  • Company has a healthy liquidity position with current ratio of 40.772.

 Limitations

  • Company has a poor ROE of 1.14583333333333% over the past 3 years.
  • Company has a poor ROCE of 0.847466666666667% over the past 3 years
  • Company has negative cash flow from operations of -6.0276431.
  • The company has a low EBITDA margin of -279.731559515765% over the past 5 years.
  • The company is trading at a high PE of 31.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 3.05 8.61 3.15 4.24 2.42
Total Expenditure 2.88 8.07 2.87 4.15 2.32
Operating Profit 0.16 0.54 0.28 0.09 0.1
Other Income 0 0.17 0 0.01 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.16 0.71 0.28 0.1 0.1
Tax 0.04 0.1 0.07 0.03 0.03
Profit After Tax 0.12 0.61 0.21 0.07 0.07
Adjusted EPS (Rs) 0.08 0.42 0.14 0.05 0.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0.01 0.02 0.17 5.79
Total Expenditure 0.01 0.12 0.07 0.55 5.74
Operating Profit -0.01 -0.11 -0.05 -0.38 0.04
Other Income 0.01 0.01 0.05 0.43 0.06
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0 -0.11 0 0.06 0.11
Tax 0 0 0 0.01 0.02
Net Profit 0 -0.11 0 0.04 0.08
Adjusted EPS (Rs.) 0 -0.22 0 0.08 0.07

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.88 4.88 4.88 4.88 11.29
Total Reserves -5.66 -5.77 -5.76 -5.72 -2.75
Borrowings 0.31 0.42 0.42 0.42 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 0.48 0.48 0.53 0.73 0.14
Total Liabilities 0.01 0.02 0.06 0.3 8.69
Assets
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0.04 0.23 2.98
Other N/C Assets 0 0 0 0 0
Current Assets 0.01 0.01 0.02 0.07 5.71
Total Assets 0.01 0.02 0.06 0.3 8.69
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0 -0.11 0 0.06 0.11
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities 0 0 0 0.01 -6.11
Tax Paid 0 0 0 -0.01 -0.02
Operating Cash Flow 0 -0.11 0 0.05 -6.03
Investing Cash Flow 0 0 0 0 0
Financing Cash Flow 0 0.1 0 0 8.88
Net Cash Flow 0 0 0 0.05 2.86

Corporate Actions

Investors Details

PARTICULARS Dec 2018% Mar 2019% Jun 2019% Sep 2019% Dec 2019%
promoters 24.30 24.30 24.30 24.30 24.30
murli nair 3.37 3.37 3.37 3.37 3.37
neha jain 3.27 3.27 3.27 3.27 3.27
niranjan jain 1.84 1.84 1.84 1.84 1.84
parikshit mahatma 3.37 3.37 3.37 3.37 3.37
rajeev mahatma 3.37 3.37 3.37 3.37 3.37
reena mahatma 3.62 3.62 3.62 3.62 3.62
sangeetaben jain 3.62 3.62 3.62 3.62 3.62
sonal mahatma 1.84 1.84 1.84 1.84 1.84
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 100.00 100.00 100.00 100.00 100.00
jagatsinh nathusinh ratho... - - - 4.10 4.10
jagrutbhai kesaribhai meh... 6.83 6.83 6.83 6.58 6.58
jaydeepa bhupendrasinh ra... - - - 4.10 4.10
jignesh shivlal makasana 11.95 11.95 11.95 11.95 11.95
kamlaba jagatsinh rathod - - - 2.24 2.24
mina surendra shah - - - 3.41 3.41
mital shreyasbhai patel - - - 1.71 1.71
parikshit mahatma 1.11 1.11 1.11 1.11 1.11
patel shivlal kuberbhai - - - 11.07 11.07
rajesh shantilal sanghvi 6.83 6.83 4.00 4.00 4.00
shah surendra nemchand 3.41 3.41 3.41 3.41 3.41
bhupendra j rathod (huf) 4.10 4.10 4.10 - -
gautam keshavlal chauhan ... 1.54 1.54 1.54 - -
jagatsing nathusingh rath... 4.10 4.10 4.10 - -
jaydeepa bhupendra rathod... 4.10 4.10 4.10 - -
kamlaba j rathod 3.70 3.70 3.70 - -
meenaben surendrakumar sh... 3.41 3.41 3.41 - -
patel mital shreyasbhai 1.71 1.71 1.71 - -
pradip narottambhai vegad... 2.95 2.95 2.95 - -
shivlal kuberbhai patel 11.95 11.95 11.95 - -
gautam chauhan 0.44 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Guj. Inject (Kerala) - Quaterly Results 14 Aug, 3:03 PM Guj. Inject (Kerala) - Quaterly Results 14 Aug, 3:03 PM Gujarat Inject (Kerala) informs about annual secretarial compliance report 30 May, 11:14 AM Guj. Inject (Kerala) - Quaterly Results 20 May, 6:12 PM Guj. Inject (Kerala) - Quaterly Results 20 May, 6:12 PM Guj. Inject (Kerala) - Quaterly Results 20 May, 6:12 PM Guj. Inject (Kerala) - Quaterly Results 23 Jan, 7:48 PM Guj. Inject (Kerala) - Quaterly Results 23 Jan, 7:48 PM Gujarat Inject (Kerala) informs about outcome of board meeting 22 Oct, 5:33 PM Guj. Inject (Kerala) - Quaterly Results 22 Oct, 4:49 PM Guj. Inject (Kerala) - Quaterly Results 22 Oct, 4:49 PM Guj. Inject (Kerala) - Quaterly Results 22 Oct, 4:49 PM Guj. Inject (Kerala) - Quaterly Results 10 Aug, 3:53 PM Guj. Inject (Kerala) - Quaterly Results 10 Aug, 3:53 PM Guj. Inject (Kerala) - Quaterly Results 10 Aug, 3:53 PM Guj. Inject (Kerala) - Quaterly Results 9 May, 5:15 PM Guj. Inject (Kerala) - Quaterly Results 9 May, 5:15 PM Guj. Inject (Kerala) - Quaterly Results 9 May, 5:15 PM Guj. Inject (Kerala) - Quaterly Results 13 Feb, 5:14 PM Guj. Inject (Kerala) - Quaterly Results 13 Feb, 5:14 PM Gujarat Inject (Kerala) informs about confirmation certificate 16 Jan, 5:18 PM Gujarat Inject (Kerala) submits corrigendum to EGM notice 8 Jan, 5:13 PM Guj. Inject (Kerala) - Quaterly Results 6 Nov, 6:22 PM Guj. Inject (Kerala) - Quaterly Results 6 Nov, 6:22 PM Guj. Inject (Kerala) - Quaterly Results 14 Aug, 4:27 PM Guj. Inject (Kerala) - Quaterly Results 22 May, 5:49 PM Guj. Inject (Kerala) - Quaterly Results 22 May, 5:49 PM Guj. Inject (Kerala) - Quaterly Results 10 Feb, 5:11 PM Guj. Inject (Kerala) - Quaterly Results 10 Feb, 5:11 PM Gujarat Inject (Kerala) informs about outcome of board meeting 31 Oct, 5:12 PM Gujarat Inject Kerala informs about newspaper advertisement 17 Oct, 12:53 PM Gujarat Inject (Kerala) informs about compliances-certificate 19 Jul, 12:55 PM Gujarat Inject Kerala informs about board meeting 24 Jun, 5:04 PM

Guj. Inject (Kerala) Stock Price Analysis and Quick Research Report. Is Guj. Inject (Kerala) an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Guj. Inject (Kerala). 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Guj. Inject (Kerala) has a PE ratio of 31.0256021814876 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Guj. Inject (Kerala) has ROA of 1.8415% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Guj. Inject (Kerala) has a Current ratio of 40.772.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Guj. Inject (Kerala) has a ROE of 3.4375%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Guj. Inject (Kerala) has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Guj. Inject (Kerala) has reported revenue growth of 3231.1126% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Guj. Inject (Kerala) for the current financial year is 0.775083017214066%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Guj. Inject (Kerala) is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Guj. Inject (Kerala) is Rs 0.6601. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Guj. Inject (Kerala) in Ticker for free. Also, one can get the intrinsic value of Guj. Inject (Kerala) by using Valuation Calculators, which are available with a Finology ONE subscription. 

Guj. Inject (Kerala) FAQs

Q1. What is Guj. Inject (Kerala) share price today?
Ans: The current share price of Guj. Inject (Kerala) is Rs 20.48.

Q2. What is the market capitalisation of Guj. Inject (Kerala)?
Ans: Guj. Inject (Kerala) has a market capitalisation of Rs 30.001152 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Guj. Inject (Kerala)?
Ans: The PE ratio of Guj. Inject (Kerala) is 31.0256021814876 and the P/B ratio of Guj. Inject (Kerala) is 2.97113013201799, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Guj. Inject (Kerala) share?
Ans: The 52-week high share price of Guj. Inject (Kerala) is Rs 29.12, and the 52-week low share price of Guj. Inject (Kerala) is Rs 17.02.

Q5. Does Guj. Inject (Kerala) pay dividends?
Ans: Currently, Guj. Inject (Kerala) does not pay dividends. Dividend yield of Guj. Inject (Kerala) is around 0%.

Q6. What are the face value and book value of Guj. Inject (Kerala) shares?
Ans: The face value of Guj. Inject (Kerala) shares is Rs 10, while the book value per share of Guj. Inject (Kerala) is around Rs 6.893. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Guj. Inject (Kerala)?
Ans: Guj. Inject (Kerala) has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Guj. Inject (Kerala)?
Ans: The ROE of Guj. Inject (Kerala) is 3.4375% and ROCE of Guj. Inject (Kerala) is 2.5424%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Guj. Inject (Kerala) a good buy for the long term?
Ans: The Guj. Inject (Kerala) long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Guj. Inject (Kerala) undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Guj. Inject (Kerala) appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Guj. Inject (Kerala)’s financials?
Ans: You can review Guj. Inject (Kerala)’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Guj. Inject (Kerala)
X